InsideArbitrage Event Driven Monitor – November 22, 2022

Quick updates on the event-driven strategies we follow on InsideArbitrage.

Merger Arbitrage

1. Imago BioSciences (IMGO) to be acquired by Merck (MRK) for $848.46 million or $36 per share in cash.
2. Alcon (ALC) completes the acquisition of Aerie Pharmaceuticals (AERI).
3. F-star Therapeutics (FSTX) and Sino Biopharmaceutical Limited amended their merger agreement by extending the end date from November 19, 2022, to December 19, 2022. The parties are in discussions with the Committee on Foreign Investment in the United States (CFIUS) regarding the transaction and have extended the end date to provide for additional time to satisfy the Foreign Investment Condition with respect to CFIUS.

Only plus or premium subscribers can access this post. Subscribe today.